Skip to content

Retail News

Walgreens hits the road for skin cancer program

Walgreens hits the road for skin cancer program

Walgreens will join The Skin Cancer Foundation on the road this year in support of its Destination: Healthy Skin Program– a national effort to educate the public about the importance of effective sun protection for skin cancer prevention, and the importance of early detection.

Metro completes Coutu acquisition

Metro completes Coutu acquisition

Metro Inc. has completed its $4.5 billion ($3.6 billion U.S.) acquisition of the Jean Coutu Group, creating a food and drug retailer with more than  1,300 stores in Quebec, Ontario and New Brunswick.

Diplomat Pharmacy names Griffin CEO

Diplomat Pharmacy names Griffin CEO

Diplomat Pharmacy Inc. announced that its board of directors has appointed Brian Griffin, executive vice president and chief executive officer of IngenioRx, the pharmacy benefit manager (PBM) of Anthem, as chief executive officer and chairman of the board of directors, effective June 4.

CVS CMO addresses population health issues at HLTH 2018

CVS CMO addresses population health issues at HLTH 2018

Today at HLTH 2018, a health care innovation conference taking place this week in Las Vegas, Nevada, CVS Health chief medical officer Dr. Troyen Brennan delivered a keynote address outlining CVS Health’s unique potential to help change current paradigms for addressing population health. Dr.

McKesson to bring ideaShare 2018 to Las Vegas

McKesson to bring ideaShare 2018 to Las Vegas

For more than 35 years McKesson’s ideaShare has been the premier education and networking event for community pharmacies. The leading conference is designed to help independent pharmacy owners and their staff improve their knowledge, performance and profitability.

Fred’s pursuing sale of specialty pharmacy business

Fred’s pursuing sale of specialty pharmacy business

During its earnings call Friday, Fred’s Inc. announced it is evaluating options for its retail pharmacy portfolio and “actively pursuing a sale” of its specialty pharmacy business, as it reported financial results for the 2017 fourth quarter and fiscal year ended February 3.